Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital
がん・感染症センター都立駒込病院
Japan
Time frame: 1 June 2025 - 30 May 2026Profile
The Nature Index tracks primary research articles from 178 applied, health, natural and social sciences journals, across many different publishers, chosen by an independent group of researchers. The Nature Index provides absolute Count of primary research articles and fractional Share counts of author contribution to articles. The positions in the table below reflect Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the corresponding table where Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital is listed.
Position by research output Share
Position by research output Share in subject areas
Research
Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital has the following research output in the current window (1 June 2025 - 30 May 2026) of the Nature Index. Click on Count to view a list of articles representing the corresponding Share value.
Overall research output
Research outputs by subject area
Leading research topics
| Topics | Count | Share |
|---|---|---|
| Oncology and Carcinogenesis | 3 | 0.13 |
| Immunology | 1 | 0.06 |
Share output for the past 5 years
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.
Collaboration
Nature Index collaborations highlight fruitful collaborations that lead to high quality research around the world. A collaboration can be between any two institutions or locations co-authoring at least one article in the journals tracked by the Nature Index. The collaboration score between two institutions is the sum of each of their Shares on the papers to which both have contributed. The table and charts below highlight the leading collaborators with Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital.
Top 5 domestic collaborators with Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital by Share
Collaborating institutions
Note: Hover over the bars to view details about each institution's Share.
| Collaborating Institution | Collaborators' Share | Collaboration Score |
|---|---|---|
| The University of Tokyo (UTokyo) | 0.06 / 0.50 | 0.56 |
| Chiba University | 0.06 / 0.29 | 0.35 |
| Edogawa Hospital | 0.06 / 0.09 | 0.15 |
| Institute of Science Tokyo (Science Tokyo) | 0.08 / 0.04 | 0.12 |
| Tokyo University of Pharmacy and Life Sciences (TUPLS) | 0.06 / 0.03 | 0.09 |
Top 5 international collaborators with Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital by Share
Collaborating institutions
Note: Hover over the bars to view details about each institution's Share.
| Collaborating Institution | Collaborators' Share | Total Share |
|---|---|---|
| La Trobe University | 0.06 / 0.16 | 0.22 |
| HealthCare Global Enterprises (HCG Enterprises) | 0.05 / 0.05 | 0.10 |
| Harbin Medical University (HMU) | 0.05 / 0.05 | 0.10 |
| Kyungpook National University (KNU) | 0.05 / 0.05 | 0.10 |
| Kyungpook National University Chilgok Hospital | 0.05 / 0.05 | 0.10 |
Job finder
Need to hire scientific researchers?
Nature Careers is visited by over 180,000 active job seekers per month that you can target directly with your role. Application response rates have increased by 28% on average over 2022 averages.
Latest supplements
Nature Index 2026 Regenerative medicine
Regenerative medicine has the potential to transform the treatment of chronic and life-threatening diseases. But major challenges remain, such as overcoming immune rejection and ensuring that new therapies are developed using more inclusive data sets. In this supplement, we explore the discoveries that are driving the field, the barriers that could limit its progress, and the teams and institutions that are making their mark.
Nature Index 2026 Nanoscience and nanotechnology
From programmable RNA architectures to next-generation materials for energy and healthcare, researchers are harnessing the unusual properties of the nanoscale to tackle some of society's biggest challenges. This supplement explores the discoveries that are driving the field, the hurdles that remain and the institutions that are leading in nanoscience and nanotechnology research.
